Cargando…

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan

Detalles Bibliográficos
Autores principales:	Matsuo, Koji, Shimada, Muneaki, Mikami, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447155/ https://www.ncbi.nlm.nih.gov/pubmed/28541644 http://dx.doi.org/10.3802/jgo.2017.28.e60

Ejemplares similares

Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan
por: Machida, Hiroko, et al.
Publicado: (2019)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
por: Matsuo, Koji, et al.
Publicado: (2021)

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
por: Matsuo, Koji, et al.
Publicado: (2019)

Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
por: Kondo, Eiji, et al.
Publicado: (2021)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery
por: Cheng, Xi, et al.
Publicado: (2004)

Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study
por: Shigeta, Shogo, et al.
Publicado: (2023)

Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy
por: Chen, Zhilan, et al.
Publicado: (2016)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Conservative management of stage IIB ovarian carcinoma with favorable oncology and fertility outcomes
por: Bartalot, Ashley, et al.
Publicado: (2021)

A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
por: Tian, Xun, et al.
Publicado: (2021)

Ovarian metastasis in women with cervical carcinoma in stages IA to IIB: A systematic review and meta-analysis
por: Fan, Yu, et al.
Publicado: (2020)

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
por: Machida, Hiroko, et al.
Publicado: (2022)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Is the ovarian preservation safe in young women with stages IB–IIA villoglandular adenocarcinoma of the uterine cervix?
por: Ju, U Chul, et al.
Publicado: (2018)

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019)

Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016)

Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database
por: Song, Xing, et al.
Publicado: (2017)

The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Chen, Bingxin, et al.
Publicado: (2020)

Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis
por: Zou, Wen, et al.
Publicado: (2019)

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
por: Chéreau, E, et al.
Publicado: (2012)

Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy
por: Huang, Kecheng, et al.
Publicado: (2016)

Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
por: Lee, Jeongshim, et al.
Publicado: (2016)

Neoadjuvant chemotherapy for locally advanced stage (IB2-IIA2-IIB) cervical carcinoma: Experience of a tertiary center and comprehensive review of the literature
por: Çakır, Caner, et al.
Publicado: (2021)

Comment on ‘Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer’
por: Peres, A, et al.
Publicado: (2012)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Are we ready for conservative treatment in ovarian cancer?
por: Utrilla-Layna, Jesus, et al.
Publicado: (2015)

Reply: Comment on ‘Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer’
por: Chéreau, E, et al.
Publicado: (2012)

Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
por: Matsuo, Koji, et al.
Publicado: (2023)

Trends of low-grade serous ovarian carcinoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment
por: Xu, Chen, et al.
Publicado: (2021)

Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I–IIB
por: Zhou, Jiansong, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Ye, Qingjian, et al.
Publicado: (2020)

CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy
por: Awazu, Yuichiro, et al.
Publicado: (2023)

Two pills and women’s health in Japan
por: Goto, Aya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bm8tblbun8ru287u8d6crui1s2